SCHEMBL6271399

SCHEMBL6271399

CC1CCC(C(=O)NCC(N)=O)CC1.CC1CCC(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 2/20 0.39
PLAT P00750 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 2/20 0.37
PSMB5 P28074 1/20 0.36
POLB P06746 1/20 0.36
OPRM1 P35372 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HSD17B10 Q99714 1/20 0.35
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
ST14 Q9Y5Y6 1/20 0.33
TRPA1 O75762 1/20 0.33
ANPEP P15144 1/20 0.33
ENPEP Q07075 1/20 0.33
EPHX1 P07099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6271761 0.93 KMT2A (0.41) PLGKMT2APSMB5POLBOPRM1
SCHEMBL6274839 0.84 EPHX1 (0.47) PLGPLATLMNAPSMB5SMN1; SMN2
SCHEMBL1651189 0.80 HSD11B1 (0.43) KMT2APSMB5POLBOPRM1SMN1; SMN2
SCHEMBL6274792 0.78 AAK1 (0.40) PSMB5SMN1; SMN2HSD17B10ANPEPEPHX1
SCHEMBL6274117 0.76 EPHX1 (0.53) KMT2APSMB5SMN1; SMN2HSD17B10EPHX1
SCHEMBL26583876 0.76 EPHX1 (0.48) KMT2APSMB5SMN1; SMN2HSD17B10EPHX1
SCHEMBL6267439 0.76 ROCK2 (0.45) LMNAKMT2APSMB5POLBSMN1; SMN2
SCHEMBL265529 0.75 LMNA (0.48) PLGPLATLMNASMN1; SMN2ANPEP
SCHEMBL135660 0.75 LMNA (0.48) PLGPLATLMNASMN1; SMN2ANPEP
SCHEMBL135662 0.75 LMNA (0.48) PLGPLATLMNASMN1; SMN2ANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606244-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT Abbott Laboratories (US) 2005-12-21 EP disclosed
WO-2004037769-A2 CYCLOALKYLAMIDES AND THEIR THERAPEUTIC USE AS ANTIEPILEPTIC AND ANTICONVULSANT ABBOTT LABORATORIES (US) 2004-05-06 WO disclosed